Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

814 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma.
Weinhold N, Försti A, da Silva Filho MI, Nickel J, Campo C, Hoffmann P, Nöthen MM, Hose D, Goldschmidt H, Jauch A, Langer C, Hegenbart U, Schönland SO, Hemminki K. Weinhold N, et al. Among authors: goldschmidt h. Leukemia. 2014 Nov;28(11):2254-6. doi: 10.1038/leu.2014.208. Epub 2014 Jul 3. Leukemia. 2014. PMID: 24990613 No abstract available.
Inherited genetic susceptibility to multiple myeloma.
Morgan GJ, Johnson DC, Weinhold N, Goldschmidt H, Landgren O, Lynch HT, Hemminki K, Houlston RS. Morgan GJ, et al. Among authors: goldschmidt h. Leukemia. 2014 Mar;28(3):518-24. doi: 10.1038/leu.2013.344. Epub 2013 Nov 19. Leukemia. 2014. PMID: 24247655 Review.
Genetic factors influencing the risk of multiple myeloma bone disease.
Johnson DC, Weinhold N, Mitchell J, Chen B, Stephens OW, Försti A, Nickel J, Kaiser M, Gregory WA, Cairns D, Jackson GH, Hoffmann P, Noethen MM, Hillengass J, Bertsch U, Barlogie B, Davis FE, Hemminki K, Goldschmidt H, Houlston RS, Morgan GJ. Johnson DC, et al. Among authors: goldschmidt h. Leukemia. 2016 Apr;30(4):883-8. doi: 10.1038/leu.2015.342. Epub 2015 Dec 16. Leukemia. 2016. PMID: 26669972 Free PMC article.
Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.
da Silva Filho MI, Försti A, Weinhold N, Meziane I, Campo C, Huhn S, Nickel J, Hoffmann P, Nöthen MM, Jöckel KH, Landi S, Mitchell JS, Johnson D, Morgan GJ, Houlston R, Goldschmidt H, Jauch A, Milani P, Merlini G, Rowcieno D, Hawkins P, Hegenbart U, Palladini G, Wechalekar A, Schönland SO, Hemminki K. da Silva Filho MI, et al. Among authors: goldschmidt h. Leukemia. 2017 Aug;31(8):1735-1742. doi: 10.1038/leu.2016.387. Epub 2016 Dec 27. Leukemia. 2017. PMID: 28025584
High-dose chemotherapy in multiple myeloma.
Goldschmidt H, Hegenbart U, Wallmeier M, Moos M, Haas R. Goldschmidt H, et al. Leukemia. 1997 Dec;11 Suppl 5:S27-31. Leukemia. 1997. PMID: 9436935 Review.
Analysis of p73 and p53 gene deletions in multiple myeloma.
Schultheis B, Krämer A, Willer A, Hegenbart U, Goldschmidt H, Hehlmann R. Schultheis B, et al. Among authors: goldschmidt h. Leukemia. 1999 Dec;13(12):2099-103. doi: 10.1038/sj.leu.2401609. Leukemia. 1999. PMID: 10602435
Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma.
Mai EK, Bertsch U, Dürig J, Kunz C, Haenel M, Blau IW, Munder M, Jauch A, Schurich B, Hielscher T, Merz M, Huegle-Doerr B, Seckinger A, Hose D, Hillengass J, Raab MS, Neben K, Lindemann HW, Zeis M, Gerecke C, Schmidt-Wolf IG, Weisel K, Scheid C, Salwender H, Goldschmidt H. Mai EK, et al. Among authors: goldschmidt h. Leukemia. 2015 Aug;29(8):1721-9. doi: 10.1038/leu.2015.80. Epub 2015 Mar 19. Leukemia. 2015. PMID: 25787915 Clinical Trial.
FOXM1 is a therapeutic target for high-risk multiple myeloma.
Gu C, Yang Y, Sompallae R, Xu H, Tompkins VS, Holman C, Hose D, Goldschmidt H, Tricot G, Zhan F, Janz S. Gu C, et al. Among authors: goldschmidt h. Leukemia. 2016 Apr;30(4):873-82. doi: 10.1038/leu.2015.334. Epub 2015 Dec 9. Leukemia. 2016. PMID: 26648534 Free PMC article.
814 results